S-Metoprolol XR 25-50 mg Tablets vs Metoprolol Zok 50-100 mg Tablets in Hypertension Patients.

A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 126 participants.

Also called NCT04457323

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; double masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 126 participants (planned count) (from the registry)
Sponsor
Neutec Ar-Ge San ve Tic A.Ş (from the registry)
Registry
  • NCT NCT04457323
Planned start
(anticipated) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Not reported
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT04457323. Randomized; double masking; primary purpose treatment. Start 2022-01-15 (anticipated); primary completion 2022-10-15 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
S-Metoprolol XR 25-50 mg Tablets vs Metoprolol Zok 50-100 mg Tablets in Hypertension Patients.
Condition
Hypertension
Intervention (Drug)
Metoprolol
Intervention (Drug)
Metoprolol
Lead sponsor
Neutec Ar-Ge San ve Tic A.Ş (class: industry)

Record details

Record id
cardio:ct-nct04457323
Content hash
1018927ef520678b726231bd41f1f5a40d72a8c2bf657969db524f7f5d40547b